Abeona Therapeutics Inc. (NASDAQ:ABEO) Q1 2026 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Abeona Therapeutics First Quarter 2026 Earnings Conference Call. [Operator instructions].
Abeona Therapeutics Inc. (ABEO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 3,100,000 | $13,888,000 | +56% | 1.89% |
| 2. | Propel Bio Management Leen Kawas And Richard Kayne | 1,329,899 | $6,007,982 | +61% | 3.79% |
| 3. | Stonepine Capital Timothy P. Lynch | 746,587 | $3,344,710 | +6% | 1.34% |
| 4. | SilverArc Capital Devesh Gandhi | 648,942 | $2,907,260 | +4% | 0.3% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 216,305 | $969,047 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.71 | 11,000 | $51,799.00 | 82,857 | 2024-05-16 | Filing | |
| $3.20 | 10,000 | $32,000.00 | 538,260 | 2024-04-25 | Filing | |
| $3.28 | 7,550 | $24,764.00 | 78,323 | 2024-04-26 | Filing | |
| $3.24 | 8,600 | $27,864.00 | 188,718 | 2024-04-25 | Filing | |
| $3.14 | 5,608 | $17,609.12 | 233,868 | 2024-04-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.96 | 5,548 | $33,073.29 | 313,071 | 2026-05-11 | Filing | |
| $4.38 | 29,985 | $131,481.23 | 1,430,423 | 2026-03-31 | Filing | |
| $4.76 | 785 | $3,736.60 | 567,775 | 2026-03-16 | Filing | |
| $5.09 | 20,070 | $102,168.34 | 137,722 | 2026-02-02 | Filing | |
| $5.09 | 14,814 | $75,412.15 | 167,935 | 2026-02-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,195,530 | $14,315,974 | 0% | |
| 2. | 2,164,851 | $9,698,532 | 0% | |
| 3. | 1,263,511 | $5,660,529 | 0.12% | |
| 4. | 956,770 | $4,286,330 | 0.47% | |
| 5. | 522,445 | $2,340,553 | 0% |
News See All
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2025 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Abeona Therapeutics Inc. full-year 2025 results conference call.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2025 Earnings Call Transcript
Operator: Good morning, everyone. And welcome to the Abeona Therapeutics third quarter 2025 conference call. At this time, all participants are in a listen-only mode.
Should You Invest in Abeona Therapeutics (ABEO)?
Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q2 2025 investor letter. A copy of the letter can be downloaded here.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q2 2025 Earnings Call Transcript
Operator: Good Day everyone, and welcome to the Abeona Therapeutics Second Quarter 2025 Conference Call.
Abeona Therapeutics, AscellaHealth Partner for Commercialization of ZEVASKYN Gene Therapy
Abeona Therapeutics Inc. (NASDAQ:ABEO) is one of the stocks under $10 to buy now.
10 Stocks Under $10 to Buy Now
Earlier on July 1, Peter Kraus, Aperture Investors chairman and CEO, joined 'Squawk Box' on CNBC to suggest that the small and mid-cap area is a place for significant growth.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q1 2025 Earnings Call Transcript
Operator: Good day and welcome to the Abeona Therapeutics First Quarter 2025 Conference Call.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2024 Earnings Call Transcript
Operator: Greetings. Welcome to Abeona Therapeutics Full Year 2024 Results and Business Update Conference Call. At this time all participants are in a listen-only mode.
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Abeona Therapeutics Third Quarter 2023 Conference Call. [Operator Instructions]. Please note this conference is being recorded.
Hedge Fund Resource Center